Showing results (371-380 of 1,343) with videos related to
Sort By:
Pageof 135
Revue Medicale De Liege|February 5, 2021
[Fixed combination atorvastatin-perindopril (Lipercosyl®) for substitution treatment of cardiovascular risk management]P Lancellotti, A Ancion, A J ScheenRevue Medicale De Liege|April 1, 2008
[Sitagliptine (Januvia): incretin enhancer potentiating insulin secretion for the treatment of type 2 diabetes]A J Scheen, L F Van GaalRevue Medicale De Liege|November 3, 2012
[Influence of body weight on the natural history of and the therapeutic approaches to type 1 diabetes]M Franck, N Paquot, A J ScheenRevue Medicale De Liege|December 8, 2015
[INITIATING AND INTENSIFYING INSULIN THERAPY IN GENERAL PRACTICE: INSUSTAR, AN OBSERVATIONAL BELGIAN PROSPECTIVE STUDY IN TYPE 2 DIABETES]A J Scheen, C Mathieu, F NobelsRevue Medicale De Liege|June 22, 2018
[Syncope in the emergencry room: Differential diagnosis and risk stratification]P Marechal, A J Scheen, P LancellottiRevue Medicale De Liege|December 30, 2004
[Percutaneous transluminal coronary angioplasty (PTCA) in diabetic patients. Part 1: failure due to restenosis after simple PTCA]F Warzée, V Legrand, A J ScheenRevue Medicale De Liege|January 22, 2005
[Percutaneous coronary angioplasty in diabetic patients: new prospects with drug-eluting stents]F Warzee, V Legrand, A J ScheenRevue Medicale De Liege|November 25, 2003
[Adiponectin: a new adipocytokine]E Lebas, N Paquot, A J ScheenRevue Medicale De Liege|August 14, 1999
[Gestational diabetes: prognostic significance for the infant]I Géronooz, A J Scheen, J SenterreRevue Medicale De Liege|December 23, 2017
[Complementarity between randomised controlled trials and observational registries : the example of cardiovascular prevention with SGLT2 inhibitors]A J Scheen, Ph Ernest, B JandrainPageof 135